Investigation on 2',3'-
Journal
ACS medicinal chemistry letters
ISSN: 1948-5875
Titre abrégé: ACS Med Chem Lett
Pays: United States
ID NLM: 101521073
Informations de publication
Date de publication:
11 Apr 2019
11 Apr 2019
Historique:
received:
01
11
2018
accepted:
26
12
2018
entrez:
19
4
2019
pubmed:
19
4
2019
medline:
19
4
2019
Statut:
epublish
Résumé
Antagonists of the purinergic P2X3 receptors represent promising drugs for the treatment of inflammation and pain. The ATP derivative 2',3'-
Identifiants
pubmed: 30996785
doi: 10.1021/acsmedchemlett.8b00524
pmc: PMC6466514
doi:
Types de publication
Journal Article
Langues
eng
Pagination
493-498Déclaration de conflit d'intérêts
The authors declare no competing financial interest.
Références
Mol Pharmacol. 2000 Dec;58(6):1502-10
pubmed: 11093790
Physiol Rev. 2002 Oct;82(4):1013-67
pubmed: 12270951
Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17179-84
pubmed: 12482951
Br J Pharmacol. 2004 Mar;141(6):1048-58
pubmed: 14980981
Mol Pain. 2006 Mar 28;2:11
pubmed: 16566843
J Med Chem. 2009 Aug 13;52(15):4596-603
pubmed: 19606867
Bioorg Med Chem Lett. 2010 Feb 1;20(3):1031-6
pubmed: 20045645
Br J Pharmacol. 2010 Jul;160(6):1387-98
pubmed: 20590629
Purinergic Signal. 2010 Jun;6(2):145-8
pubmed: 20806006
Adv Pharmacol. 2011;61:333-72
pubmed: 21586364
Pharmacol Rev. 2011 Sep;63(3):641-83
pubmed: 21737531
J Neurochem. 2012 Aug;122(3):557-67
pubmed: 22639984
J Med Chem. 2012 Nov 26;55(22):9576-88
pubmed: 23075067
Front Cell Neurosci. 2013 Oct 28;7:191
pubmed: 24191146
Curr Med Chem. 2015;22(7):819-44
pubmed: 25005189
Curr Med Chem. 2015;22(7):845-50
pubmed: 25312207
Eur J Med Chem. 2015 Jan 7;89:561-80
pubmed: 25462266
Lancet. 2015 Mar 28;385(9974):1198-205
pubmed: 25467586
Curr Med Chem. 2015;22(7):915-28
pubmed: 25515515
Curr Med Chem. 2015;22(7):929-41
pubmed: 25524251
Curr Med Chem. 2015;22(7):782
pubmed: 25645748
Nature. 2016 Oct 6;538(7623):66-71
pubmed: 27626375
Purinergic Signal. 2017 Mar;13(1):61-74
pubmed: 27757785
Biochem Pharmacol. 2017 Feb 1;125:41-54
pubmed: 27867013
Br J Pharmacol. 2018 Jun;175(12):2219-2230
pubmed: 28728214
J Mol Biol. 1997 Apr 4;267(3):727-48
pubmed: 9126849
Mol Pharmacol. 1998 Jun;53(6):969-73
pubmed: 9614197